Categories
Loading...
Categories
The company highlighted its global animal health presence (35+ countries, 3 plants), leading PPR and LSD vaccine markets. FY26 consolidated revenue hit ₹332.60 Cr. Strategic focus includes R&D and expanding its Petcare division in India.